IF by specialty › Rheumatology
Therapeutic Advances in Musculoskeletal Disease — Impact Factor
The 2025 Impact Factor of Therapeutic Advances in Musculoskeletal Disease is 3.3 (Q2 in Rheumatology; fully open access).
- Impact Factor
- 3.3 JCR 2025
- JCR category
- Rheumatology
- Quartile
- Q2 in Rheumatology
- Publisher
- SAGE
- Open access
- fully open access
- IF source
- journals.sagepub.com
Position within the field
Ranked 18 of the 33 journals in Rheumatology on this site (bottom 50%).
Rheumatology journals with a similar Impact Factor
- The Journal of Rheumatology IF 3.7
- Rheumatology International IF 3.5
- Rheumatology and Therapy IF 3.1
- BMC Rheumatology IF 3.1
- Osteoarthritis and Cartilage Open IF 2.9
- ACR Open Rheumatology IF 2.9
About this value
The Journal Impact Factor of Therapeutic Advances in Musculoskeletal Disease (JCR 2025, released June 2026) is 3.3. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Rheumatology.